A randomized study to assess the immunogenicity, antibody persistence and safety of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in children aged 2-10 years.
Vesikari T; Forstén A; Boutriau D; Bianco V; Van der Wielen M; Miller JM; Human Vaccines & Immunotherapeutics, 2012, vol. 8, issue 12, p 1882, ISSN 2164554x. ISBN 2164554x.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef